DOE Isotope Program Highlights

News highlights from all participating national laboratories, university facilities, and other research institutions which feature work from the U.S. Department of Energy Isotope Program can be found here.

Image courtesy of Brown, M.A., Metal Oxide Sorbents for the Separation of Radium and Actinium, Industrial & Engineering Chemistry Research, 59, 20472-20477 (2020). [DOI: 10.1021/acs.iecr.0c04084] The separation of radium and actinium is a major component in the production, distribution, and purity of targeted alpha therapy isotopes. This image shows the separation profiles of radium (purple) and actinium (green) across a zirconia resin.

Scientists Develop Inorganic Resins for Generating and Purifying Radium and Actinium

Research advances the chemistry and improves the purity of isotopes for targeted alpha therapy used in the treatment of cancers.
Read the full highlight
Image courtesy of Gauthier Deblonde, Lawrence Livermore National Laboratory This photograph is a rare example of a curium compound (isotopes Cm-248/246). This is a Cm(III)-polyoxometalate complex isolated and characterized using the newly proposed technique that required only 1-10 micrograms of the precious radioisotope.

New Strategy Can Harvest Chemical Information on Rare Isotopes with a Fraction of the Material

A newly proposed approach aids chemical studies of rare, toxic, radioactive, and precious isotopes by requiring 1,000 times less material.
Read the full highlight
Image courtesy of Jaimee Janiga, Oak Ridge National Laboratory

Getting Purer Berkelium, Faster than Ever

This new method individually separates heavy metals — an actinide chemist’s dream.
Read the full highlight
Left: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomography (PET) image of a patient with metastatic colon cancer, obtained using gallium-68 (Ga-68)

Fighting Cancer on Earth and in Space Using High-Energy Protons

Scientists on Earth use high-energy protons to create isotopes to detect and treat cancer. In space, however, these same high-energy protons can pose a risk to spacecraft and the health of the astronauts traveling in them.
Read the full highlight
Image courtesy of Texas A&M University The medical radioisotope astatine is separated from bismuth then loaded into a resin column. Once dry, the column is packed for shipping so the astatine can be sent for use at a cancer treatment center.

Cancer Countermeasures on a Column

University researchers produce a novel method of shipping the promising medical isotope astatine-211
Read the full highlight
Image courtesy of Oak Ridge National Laboratory and Army Research Laboratory. Direct deposition of a radioisotope source onto a converter. This can improve conversion of the radioisotope source’s beta decay emissions to electricity by using two converters instead of one. The result is greater power density for the power source.

New Approach to Radioisotope Power Sources for Improved Efficiency, Long Life

NextGen power sources may satisfy the need for long-term, compact power for use in remote or extreme environments.
Read the full highlight
Image courtesy of Carlos Jones, Oak Ridge National Laboratory Researcher Sandra Davern looks at non-radioactive metal ions enclosed in biodegradable polymers in her lab at Oak Ridge National Laboratory. Her work is paving the way for enclosing isotopes in the same polymers for targeted treatment of cancer cells.

Enclosing Radiation-Loaded Particles to Better Seek and Destroy Cancer

Promising study details how radioactive agents could be sent directly to cancer cells.
Read the full highlight
Image courtesy of Jon Burns, Texas A&M University At-211 – ketone interaction within the chromatography column.

New Elegant Method for Rapid Recovery of Anti-Cancer Agent At-211

A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.
Read the full highlight
Image courtesy of Donald Montoya, Los Alamos National Laboratory Cerium-134 can be targeted to provide an imaging analogue for two different therapy isotopes, actinium-225 and thorium-227. This helps scientists understand these therapy isotopes and develop new treatments. These novel isotopes are being developed and produced by the DOE Isotope Program.

New Imaging Isotope Meets Promising Therapy Isotopes

New production methods for Ce-134 advance technologies for imaging human disease and guiding treatment.
Read the full highlight
Julie Ezold has been elected to a three-year term on the American Nuclear Society’s Board of Directors.

Ezold elected to the ANS Board of Directors

Julie Ezold, section head at ORNL, has been elected to a three-year term on the American Nuclear Society’s Board of Directors.
Read the full highlight